secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001493152-23-034627
Event type: debt
Sentiment:  positive
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics enters waiver with Alpha Capital to pay October 2023 debenture redemption in shares
--------------------------------------------------------------------------------

- Waiver applies to $3.3M 8% Senior Convertible Debenture issued Dec 22, 2022.
- Alpha consents to paying the October 2023 Monthly Redemption Amount in Conversion Shares.
- Alpha waives the Equity Conditions requirement for the October Payment.
- No other terms of the Debenture are amended.
- Effective September 22, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/0001493152-23-034627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-034627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer